inogatran
inogatran Basic information
- Product Name:
- inogatran
- Synonyms:
-
- inogatran
- H-314-27
- Glycine, N-[(1R)-2-[(2S)-2-[[[3-[(aminoiminomethyl)amino]propyl]amino]carbonyl]-1-piperidinyl]-1-(cyclohexylmethyl)-2-oxoethyl]-
- Inogatran (H-314-27)
- CAS:
- 155415-08-0
- MF:
- C21H38N6O4
- MW:
- 438.56
- Mol File:
- 155415-08-0.mol
inogatran Chemical Properties
- Density
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- pka
- 2.16±0.10(Predicted)
inogatran Usage And Synthesis
Uses
Inogatran (H-314-27) is a synthetic thrombin inhibitor, developed for the possible treatment and prophylaxis of arterial and venous thrombotic diseases.
in vivo
Inogatran (H-314-27; 0.075, 0.25, 0.75 mg/kg, i.v.) results in dose-dependent increases in activated partial thromboplastin time (aPTT), thrombin time (TT), and prothrombin time (PT) in a canine electrolytic injury model of venous thrombosis[1].
Inogatran dose-dependently inhibits thrombus formation, which is measured as an increase in time to occlusion (TTO) and a decrease in thrombus weight. Inogatran also improves vena caval blood flow and reduces the overall incidence of thrombotic occlusion in a rat model[2].
References
[1] Ignasiak DP, et al. Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog. J Thromb Thrombolysis. 1998 Nov;6(3):199-206. DOI:10.1023/A:1008806312396
[2] Chi L, et al. Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran. J Thromb Thrombolysis. 2001 Feb;11(1):19-31. DOI:10.1023/a:1008900109285
inogatranSupplier
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Tel
- 010-60605840 15801484223;
- psaitong@jm-bio.com
- Tel
- 4008200310
- marketing@tsbiochem.com
- Tel
- 1173954148q
- meishipharma@126.com
inogatran(155415-08-0)Related Product Information
- N-ethylpiperidine-2-carboxamide
- METHYL[(1-PROPYLPIPERIDIN-2-YL)METHYL]AMINE
- (1-BUTYL-2-PIPERIDINYL)-N-METHYLMETHANAMINE
- N-[(1-BUTYL-2-PIPERIDINYL)METHYL]ETHANAMINE
- N-[(1-ETHYL-2-PIPERIDINYL)METHYL]-1-PROPANAMINE
- ETHYL[(1-ETHYLPIPERIDIN-2-YL)METHYL]AMINE
- Pipecolamide
- N-[(1-PROPYL-2-PIPERIDINYL)METHYL]-1-PROPANAMINE
- N-methylpiperidine-2-carboxamide
- ETHYL[(1-METHYLPIPERIDIN-2-YL)METHYL]AMINE
- N-[(1-METHYL-2-PIPERIDINYL)METHYL]-1-PROPANAMINE
- ETHYL[(1-PROPYLPIPERIDIN-2-YL)METHYL]AMINE
- inogatran
- N-[(1-BUTYL-2-PIPERIDINYL)METHYL]-1-PROPANAMINE
- AKOS BC-0095
- CHEMBRDG-BB 4015189